Vaccines, products and technologies
Our expertise is based on a technical, strategic and innovative approach aimed at supporting governments and international partners in structuring, evaluating and improving vaccination and health product management policies. By combining technical assistance, institutional capacity building and process digitalisation, we help to ensure quality healthcare that is accessible to all.
projects
years of experience
Areas of expertise
In the face of growing global public health challenges, ensuring equitable access to vaccines and essential health products is a strategic priority.
Establishing sustainable vaccination systems, strengthening drug supply chains and optimising health technologies are fundamental levers for improving the resilience of health systems.
Vaccination
Pharmaceutical products and supply
Vaccination
We support the governance and sustainability of vaccination programmes by strengthening routine vaccination services, improving logistics and ensuring efficient cold chain management.
Our approaches incorporate gender-sensitive programming to ensure equitable access to vaccines.
In collaboration with key sector partners such as Gavi, the Vaccine Alliance, we contribute to the prevention of vaccine-preventable diseases and the fight against epidemics such as polio, tuberculosis and malaria.
Our references in vaccines, products and technologies
Dedicated teams
Ginger SOFRECO's Health Division employs around 15 people at its head office, all with proven expertise in international project management and a health-related field (doctors, pharmacists, public health specialists, etc.).
The permanent team at head office is reinforced by dozens of regular colleagues, each an expert in their field (hospital construction, health development, health economists, etc.).
colleagues in the field (in-house staff and associated experts)
people
They trust us
Challenges and prospects
The effective financing, management and deployment of vaccination programmes and supply chains
Many countries need to strengthen their capacity to finance, manage and effectively deploy their vaccination programmes and drug supply chains. This involves implementing appropriate strategies to ensure the continuity of essential services, prevent stock shortages, ensure equitable distribution of health products and leverage technological innovations for optimised management and monitoring.
In response to these challenges, our approach aims to support governments and national institutions in developing autonomous, resilient health policies that are tailored to their socio-economic settings. We support a gradual and controlled transition of financing and responsibilities towards sustainable health systems that are better prepared for future challenges.
Contact us
